Clinical trial
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating…
NCT00021450 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00021450 |
|---|---|
| Title | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer |
| Official title | Three Dimensional Conformal Radiotherapy / Intensity Modulated Radiotherapy Alone Vs Three Dimensional Conformal Therapy / Intensity Modulated Radiotherapy Plus Adjuvant Hormonal Therapy In Localized T1b-c, T2a, N0, M0 Prostatic Carcinoma. A Phase III Randomized Study |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | bicalutamide, goserelin acetate, adjuvant therapy, radiation therapy |
| Enrollment | 819 |
| Start date | Apr 1, 2001 |
| Primary completion | Apr 1, 2008 |
| Completion | Jan 1, 2016 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 2, 2016 |
| Countries | Belgium, Cyprus, Czechia, France, Ireland, Italy, Luxembourg, Netherlands, Poland, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: